 Home |
|
About Us |
|
Career |
|
Scientific Advisors |
|
Board of Directors |
|
Management |
|
About Us |
|
Research & Development |
|
Technology Platform |
|
Protein Optimization Service |
|
Protein Optimization Process |
|
FIND Technology |
|
Immunotherapy of Cancer (IMCAN) |
|
ADC-1004 |
|
Pipeline |
|
Research & Development |
|
Partners |
|
Investors |
|
News & Press |
|
8 januari 2010, Alternativa Aktiemarknaden |
|
11 January 2010, Alligator Bioscience´s protein drug candidate ADC-1004 |
|
20 januari 2010, Alternativa aktiemarknadens initiativ |
|
12 april 2010, Ledningsförändringar i Alligator Bioscience AB |
|
14 June 2010, Alligator Bioscience AB appoints Sibylle Lenz as Chief Executive Officer |
|
8 February 2011, Peter Benson, new associated member of Board of Directors, Alligator Bioscience AB |
|
31 March 2011, Alligator Bioscience AB raises 43 MSEK in directed new share issue. |
|
11 maj 2011, Kallelse till årsstämma i Alligator Bioscience AB |
|
12 maj 2011, Alligator Bioscience AB genomför företrädesemission. |
|
9 juni 2011, Förlängning av teckningstiden i pågående företrädesemission |
|
9 Juni 2011, Peter Benson invald i styrelsen för Alligator Bioscience AB. |
|
4 Juli, 2011. Alligator Bioscience AB har tagit in ytterligare kapital. |
|
19 December, 2011. Project Update on ADC-1004 |
|
Contact Us |
|
Meet Us |
|
Contact Us |